What type of data is collected from wholesalers regarding drug transactions?

The correct answer is sales data, which encompasses detailed information about the sale of drugs from wholesalers to healthcare providers. This data typically includes quantities of drugs sold, prices, discounts, rebate information, and other transaction-specific metrics. It plays a crucial role in ensuring compliance with the 340B Program, as accurate sales data is necessary to determine eligibility for program discounts and to track the flow of drugs within participating entities.

Billing information relates to the charges and financial aspects of transactions, but does not specifically capture the sales transactions themselves. Inventory records focus on the quantities of drugs available on-hand, which while important for overall drug management, do not detail the sales movements of those products. Patient data involves individual patient information and is not collected from wholesalers; instead, it pertains to healthcare delivery and treatment outcomes. Hence, while all these data types are relevant in a healthcare context, sales data is the specific type needed to monitor drug transactions in relation to the 340B Program.